As of January 22, 2025, Ultragenyx (RARE) has a market cap of $3.96 billion USD. According to our data, Ultragenyx is ranked No.3041 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $3.96 B |
1.85%
|
Dec 31, 2024 | $3.88 B |
-12.02%
|
Dec 29, 2023 | $4.42 B |
3.22%
|
Dec 30, 2022 | $4.28 B |
-44.90%
|
Dec 31, 2021 | $7.77 B |
-39.25%
|
Dec 31, 2020 | $12.78 B |
224.12%
|
Dec 31, 2019 | $3.94 B |
-1.77%
|
Dec 31, 2018 | $4.02 B |
-6.25%
|
Dec 29, 2017 | $4.28 B |
-34.03%
|
Dec 30, 2016 | $6.49 B |
-37.32%
|
Dec 31, 2015 | $10.36 B |
155.65%
|
Dec 31, 2014 | $4.05 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Vertex Pharmaceuticals
VRTX
|
$110.70 B |
-0.001 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.81 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.08 B |
-0.000 M
|
USA
|
Moderna
MRNA
|
$14.88 B |
0.000 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
Illumina
ILMN
|
$22.13 B |
-0.001 M
|
USA
|
Catalyst Pharmaceuticals
CPRX
|
$2.74 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.30 B |
0.000 M
|
USA
|
ACADIA Pharmaceuticals
ACAD
|
$2.97 B |
0.000 M
|
USA
|
Market Cap | = | RARE Stock Price | * | RARE Shares Outstanding |
= | $42.85 | * | 92.34 M | |
= | $3.96 B |